Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 250

1.

Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study.

Chen YB, Mu CY, Huang JA.

Tumori. 2012 Nov;98(6):751-5. doi: 10.1700/1217.13499.

PMID:
23389362
[PubMed - indexed for MEDLINE]
2.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
[PubMed - indexed for MEDLINE]
3.

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation.

Mu CY, Huang JA, Chen Y, Chen C, Zhang XG.

Med Oncol. 2011 Sep;28(3):682-8. doi: 10.1007/s12032-010-9515-2. Epub 2010 Apr 6.

PMID:
20373055
[PubMed - indexed for MEDLINE]
4.

Analysis of MAT3 gene expression in NSCLC.

Zheng S, Du Y, Chu H, Chen X, Li P, Wang Y, Ma Y, Wang H, Zang W, Zhang G, Zhao G.

Diagn Pathol. 2013 Oct 9;8:166. doi: 10.1186/1746-1596-8-166.

PMID:
24107548
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, Nakamura S, Enomoto K, Yagita H, Azuma M, Nakajima Y.

Clin Cancer Res. 2007 Apr 1;13(7):2151-7.

PMID:
17404099
[PubMed - indexed for MEDLINE]
Free Article
6.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

PMID:
18705409
[PubMed - indexed for MEDLINE]
7.

Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.

Lin Q, Chen T, Lin Q, Lin G, Lin J, Chen G, Guo L.

J Surg Oncol. 2013 Jun;107(7):767-71. doi: 10.1002/jso.23312. Epub 2013 Apr 23.

PMID:
23609137
[PubMed - indexed for MEDLINE]
8.

Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.

Gao Q, Yang S, Kang MQ.

Mol Med Rep. 2012 Jun;5(6):1409-14. doi: 10.3892/mmr.2012.840. Epub 2012 Mar 19.

PMID:
22446832
[PubMed - indexed for MEDLINE]
9.

Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.

Grah JJ, Katalinic D, Juretic A, Santek F, Samarzija M.

Tumori. 2014 Jan-Feb;100(1):60-8. doi: 10.1700/1430.15817.

PMID:
24675493
[PubMed - indexed for MEDLINE]
10.

Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.

Xu YJ, Shao YF, Zhao X, Geng YT, Wang K, Yin YM.

J Cancer Res Clin Oncol. 2011 Dec;137(12):1841-8. doi: 10.1007/s00432-011-1054-5. Epub 2011 Sep 17.

PMID:
21927908
[PubMed - indexed for MEDLINE]
11.

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.

Zhan P, Shen XK, Qian Q, Wang Q, Zhu JP, Zhang Y, Xie HY, Xu CH, Hao KK, Hu W, Xia N, Lu GJ, Yu LK.

Oncol Rep. 2012 Apr;27(4):1072-8. doi: 10.3892/or.2011.1605. Epub 2011 Dec 21.

PMID:
22200856
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.

Zhang Z, Ma J, Li N, Sun N, Wang C.

Ann Thorac Surg. 2006 Jul;82(1):243-8.

PMID:
16798222
[PubMed - indexed for MEDLINE]
13.

Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.

Xu XY, Lin N, Li YM, Zhi C, Shen H.

Pathol Res Pract. 2013 Jun;209(6):345-52. doi: 10.1016/j.prp.2013.02.015. Epub 2013 Mar 25.

PMID:
23602236
[PubMed - indexed for MEDLINE]
14.

Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.

Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA, Ross JS.

Ann Diagn Pathol. 2004 Feb;8(1):6-16.

PMID:
15129904
[PubMed - indexed for MEDLINE]
15.

High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.

Feng J, Zhang X, Zhu H, Wang X, Ni S, Huang J.

Am J Clin Pathol. 2012 Aug;138(2):230-5. doi: 10.1309/AJCPDHQFNYJZ01YG.

PMID:
22904134
[PubMed - indexed for MEDLINE]
Free Article
16.

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, Semeraro A, Del Sordo R, Tofanetti FR, Mameli MG, Daddi G, Cavaliere A, Tonato M, Crinò L.

Ann Oncol. 2009 May;20(5):842-9. doi: 10.1093/annonc/mdn727. Epub 2009 Jan 19.

PMID:
19153117
[PubMed - indexed for MEDLINE]
Free Article
17.

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.

Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11.

PMID:
18550205
[PubMed - indexed for MEDLINE]
18.

Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance.

Han WL, Li WD, Hu J, Rusidanmu A, Chen LF, Shen L, Zheng SS.

Chin Med J (Engl). 2012 Mar;125(6):1110-4.

PMID:
22613539
[PubMed - indexed for MEDLINE]
Free Article
19.

Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis.

Liu JL, Wang XY, Huang BX, Zhu F, Zhang RG, Wu G.

Med Oncol. 2011 Sep;28(3):673-8. doi: 10.1007/s12032-010-9510-7. Epub 2010 Mar 31.

PMID:
20354813
[PubMed - indexed for MEDLINE]
20.

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.

Anagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN.

BMC Cancer. 2010 May 9;10:186. doi: 10.1186/1471-2407-10-186.

PMID:
20459695
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk